Nalaganje...
Long-Term Safety of Dapagliflozin in Older Patients with Type 2 Diabetes Mellitus: A Pooled Analysis of Phase IIb/III Studies
OBJECTIVE: To evaluate the 104-week safety of dapagliflozin in older patients with type 2 diabetes mellitus. METHODS: Pooled analysis assessing general safety (nine phase III studies ≤104 weeks) and cardiovascular safety (21 phase IIb/III studies ≤208 weeks) by age (<65; ≥65; ≥75 years). Patients...
Shranjeno v:
| izdano v: | Drugs Aging |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer International Publishing
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4937081/ https://ncbi.nlm.nih.gov/pubmed/27357173 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40266-016-0382-1 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|